Somagen, Spectral in WNV (West Nile virus) test pact:
This article was originally published in Clinica
Canadian diagnostics developer Spectral Diagnostics has appointed Somagen Diagnostics as distributor of its rapid West Nile virus (WNV) test in its home market. By enabling the diagnosis for WNV to be made rapidly and in under an hour, the test allows doctors to intervene more quickly and manage more effectively the complications of WNV infection, including meningoencephalitis, says Toronto-based Spectral.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.